The National Institute for Health and Care Excellence (NICE) has today published its final updated guidance on the use of tumour profiling tests...

19 December 2018

Responding to NICE final guidance that three tumour profiling tests will be available to guide adjuvant chemotherapy decisions in people with early...

19 December 2018

New research published today in the British Journal of Cancer has found that women who experience a ‘false positive’ result following a mammogram are...

19 December 2018

Responding to the publication of the Independent Breast Screening Review report, announced in May following a serious incident in the screening...

13 December 2018

Responding to news that the Scottish Medical Consortium (SMC) has approved the use of pertuzumab (Perjeta) for neo-adjuvant treatment of HER2-...

10 December 2018

Breast Cancer Now has welcomed the Scottish Medicines Consortium’s (SMC) decision to approve breast cancer drug Perjeta (pertuzumab) as a new...

10 December 2018

Earlier this month, the US Food and Drug Administration (FDA) approved the use of a drug called talazoparib (Talzenna), to treat BRCA-mutated locally...

6 December 2018

Responding to a parliamentary question answered by Scottish Government, which reveals that there is a backlog in breast screening in some areas of...

5 December 2018

NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use, a...

4 December 2018